Increase My T

Increase My T operates as a telehealth-focused hormone optimization clinic serving patients throughout Florida from its Naples base. Board-certified provider Todd leads the practice with a clinical focus on testosterone replacement therapy, metabolic health interventions, and peptide-based weight management protocols. The clinic structures treatment around measurable hormone panels and body composition metrics rather than symptom management alone, positioning itself for patients seeking data-driven approaches to age-related hormone decline and metabolic dysfunction.

The clinic's peptide offerings center on two primary GLP-1 receptor agonists: semaglutide and tirzepatide. Semaglutide protocols typically begin at 0.25 mg weekly with titration based on tolerance and weight loss response, while tirzepatide programs leverage its dual GIP/GLP-1 mechanism for patients requiring more aggressive metabolic intervention. Todd integrates these peptides with testosterone replacement therapy for patients presenting with both hypogonadism and insulin resistance, a common clinical overlap in men over 40. The clinic does not offer growth hormone secretagogues or tissue repair peptides as part of its current formulary, maintaining focus on hormone replacement and metabolic peptides with established clinical evidence.

Todd's board certification provides the clinical foundation for prescribing controlled substances including testosterone cypionate and enanthate, which form the backbone of the clinic's TRT protocols. Initial consultations include review of recent lipid panels, complete metabolic panels, and hormone assays (total testosterone, free testosterone, estradiol, SHBG) to establish baseline values. Todd adjusts testosterone dosing and injection frequency based on follow-up labs typically drawn at 6-week intervals during titration phases. For patients on semaglutide or tirzepatide, the clinic monitors HbA1c, fasting glucose, and liver enzymes quarterly to track metabolic improvements and screen for adverse effects.

Patients access Increase My T exclusively through telehealth video consultations, eliminating the need for in-person clinic visits in Naples or elsewhere in Florida. The virtual care model requires patients to arrange their own laboratory work through local Quest or LabCorp facilities, with results reviewed during scheduled follow-up appointments. Prescriptions for testosterone, syringes, and peptides ship directly to patient homes from partner compounding pharmacies. This structure works best for self-sufficient patients comfortable with subcutaneous or intramuscular self-injection and able to coordinate their own phlebotomy appointments. The clinic does not provide in-office injection training or physical examinations.

Increase My T differentiates itself through its Florida-specific telehealth licensing and its combination approach to male hormone optimization and weight management. Todd's willingness to prescribe both testosterone and GLP-1 peptides within a single treatment plan addresses the clinical reality that many men with low testosterone also present with elevated body fat percentages and insulin resistance. The clinic maintains a narrow scope—it does not treat female patients, does not offer bioidentical hormone pellets, and does not provide peptides for athletic performance or anti-aging outside of metabolic and hormonal contexts. This focused model allows for streamlined protocols and clear patient selection criteria centered on men seeking medically supervised hormone replacement and weight loss in Florida.